International Game Technology PLC header image

International Game Technology PLC

IGT

Equity

ISIN GB00BVG7F061 / Valor 27140232

New York Stock Exchange, Inc (2026-04-24)
USD 12.92+0.94%

International Game Technology PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

International Game Technology PLC (IGT) is a global leader in gaming, providing a wide array of products and services across various sectors of the industry. The company's offerings span from digital and interactive solutions to traditional retail betting systems, catering to the diverse needs of the regulated iGaming market and sportsbook operators. IGT's PlayDigital Casino platform is renowned for its high-quality, omni-channel content, which includes a comprehensive suite of games and business solutions designed to meet the evolving demands of online gaming. Additionally, IGT PlaySports is recognized for its industry-leading, business-to-business retail betting solutions, offering a full suite of services tailored for sportsbook operations. The company's commitment to innovation is evident in its extensive portfolio, which is built upon advanced technologies, leading analytics, and in-depth research, ensuring that IGT remains at the forefront of the gaming industry's technological and regulatory developments.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (07.04.2026):

International Game Technology PLC's fourth quarter of 2024 results show the company met its outlook: Q4 revenue was $651 million (down 4% vs. Q4 2023), income from continuing operations was $116 million (17.9% margin) and Adjusted EBITDA was $290 million (44.5% margin). For the full year 2024, revenue was $2.512 billion, income from continuing operations was $271 million (10.8% margin), and Adjusted EBITDA was $1.17 billion. Management highlighted strong instant ticket and draw-game performance, robust cash generation, and the announced $4.05 billion sale of the Gaming & Digital business.

Q4 2024 — headline financials

Revenue $651M (-4% Y/Y), income from continuing operations $116M (17.9% margin), Adjusted EBITDA $290M (-8% Y/Y) with a 44.5% margin; diluted EPS from continuing ops $0.40 (adjusted EPS $0.22).

Full-year 2024

Revenue $2.512B (flat YoY), Adjusted EBITDA $1.17B (−4% YoY) with a 46.6% margin, income from continuing operations $271M, and diluted EPS from continuing ops $0.57 (adjusted EPS $0.67).

Cash flow and free cash

Consolidated cash from operations was $1.03B for 2024 (including $689M from continuing operations). The release cites consolidated free cash flow of $659M with over 80% generated by continuing operations.

Balance sheet & liquidity

Cash & equivalents $584M at 12/31/2024, total liquidity $1.9B (including ~$1.4B borrowing capacity). Net debt was $4.78B (vs. $5.16B a year earlier).

Major corporate action

Announced sale of the Gaming & Digital business to affiliates of Apollo Global Management for $4.05B in cash (expected to close by end of Q3 2025).

Operational trends

Strong instant ticket and draw-game same-store sales across jurisdictions (Italy same-store growth notable: Q4 Italy instant games +7.0%, normalized 3.9%). U.S. multi-state jackpot activity was elevated in the prior-year comparator, weighing on Y/Y comparisons.

2025 outlook & guidance

Full-year 2025 guidance: revenue $2.55–$2.65B (low‑mid single-digit growth), Adjusted EBITDA $1.10–$1.15B. Company expects H1'25 impact from lower U.S. multi-state jackpot activity and plans ~$25M incremental investment in growth initiatives; capex ~ $450M.

Capital return & other corporate items

Board declared a quarterly cash dividend of $0.20 per common share (record date March 11, 2025; payment March 25, 2025).

Summarized from source with an LLMView Source

Key figures

-20.8%1Y
-54.7%3Y
-22.0%5Y

Performance

36.3%1Y
36.4%3Y
45.2%5Y

Volatility

Market cap

2384 M

Market cap (USD)

Daily traded volume (Shares)

936,350

Daily traded volume (Shares)

1 day high/low

17.4 / 16.83

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Netflix Inc
Netflix Inc Netflix Inc Valor: 1413346
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 92.44
NVIDIA Corp
NVIDIA Corp NVIDIA Corp Valor: 994529
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.32%USD 208.27
Advanced Micro Devices Inc
Advanced Micro Devices Inc Advanced Micro Devices Inc Valor: 903491
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
13.91%USD 347.81
Alphabet Inc
Alphabet Inc Alphabet Inc Valor: 29798545
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.35%USD 342.32
SK hynix Inc
SK hynix Inc SK hynix Inc Valor: 18382960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.38%EUR 744.00
Brady Corp
Brady Corp Brady Corp Valor: 913942
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.69%USD 80.70
Marvell Technology Inc
Marvell Technology Inc Marvell Technology Inc Valor: 111229262
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.76%USD 164.31
CDW Corporation
CDW Corporation CDW Corporation Valor: 21034308
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%USD 135.32
Biomarin Pharmaceutical Inc
Biomarin Pharmaceutical Inc Biomarin Pharmaceutical Inc Valor: 729021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.48%USD 53.18
Kura Oncology Inc
Kura Oncology Inc Kura Oncology Inc Valor: 28160920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.11%USD 9.26